CMS on November 16 proposed to recover Medicare Advantage risk adjustment payments by applying the error found in a sample of audited medical records to every enrollee in the contract, starting with payment year 2018 and with no fee-for-service (FFS) adjuster. The proposal reissues a 2023 rule that a federal court in Texas vacated in September 2025, and it reaches the roughly 590 contracts CMS audits for each payment year.
The audit policy is part of a 545-page proposed rule, Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH), CMS-6098-P, scheduled for Federal Register publication on November 19. CMS estimates the Risk Adjustment Data Validation (RADV) audits would move $90.2 billion from MA organizations to the federal government over 2027 to 2036. Its press release put savings from the whole rule at "nearly $90 billion."
Health insurer shares were sold for a second day on Wednesday, Yahoo Finance reported. Humana was down 13.0% and UnitedHealth Group 10.2% at Wednesday's close. Medicare products were about 85% of Humana's premiums and services revenue in the first nine months of 2026, according to its third-quarter 10-Q.
Key Takeaways
- CMS built its $90.2 billion estimate on an average overpayment of $1,258 per sampled enrollee, applied to about 71.7 million enrollees across 8,260 contract audits.
- Projected collections over 2027 to 2036 peak early, at $16.8 billion in each of 2028 and 2029 and $13.6 billion in 2030, before settling at $6.8 billion a year.
- The same audits would collect $439.1 million over the decade without extrapolation, CMS said, and the audit program would cost more than it recovers.
- CMS rested the missing adjuster on a 2021 D.C. Circuit ruling. Humana's certified bids through payment year 2027 preserved its position that an adjuster must apply to any extrapolated audit.
- Humana shares closed down 13.0% and UnitedHealth's 10.2% on Wednesday, the second day of selling after the release.
- Comments are due January 19, 2027, while the government's appeal of the 2025 court ruling is pending at the Fifth Circuit.
What CMS proposed and how the $90.2 billion is spread
Proposed section 422.311(a)(2) reads: "CMS may apply extrapolation to audits for payment year 2018 and subsequent payment years." CMS said it intends extrapolation to be "the standard practice" from that year on. Audited organizations would repay through offsets to their monthly capitation payments, spread over several months with interest when the amount exceeds one month's payment.
The regulatory impact analysis puts recoveries at $2.2 billion in 2027, $16.8 billion in each of 2028 and 2029 and $13.6 billion in 2030, then $6.8 billion a year through 2036. The three peak years carry $47.2 billion, or 52% of the ten-year total. The CMS fact sheet gives the average as about $9 billion per payment year.
CMS estimate of RADV collections by calendar year
| Calendar year | With extrapolation ($ billions) | Without the rule ($ millions) |
|---|---|---|
| 2027 | 2.2 | 18.0 |
| 2028 | 16.8 | 83.9 |
| 2029 | 16.8 | 85.3 |
| 2030 | 13.6 | 63.0 |
| 2031 to 2036, each year | 6.8 | 31.5 |
| Ten-year total | 90.2 | 439.1 |
Sources: CMS, CRUSH proposed rule (CMS-6098-P), Tables C-B5 and C-B6. Extrapolated figures rounded from $ millions.
Audits for the early years are already open. Humana's 10-Q says CMS has initiated RADV audits for payment years 2018 through 2021 and 2024, selecting Humana contracts in every one of them.
Without extrapolation, CMS estimated, the same audits would collect $439.1 million over the decade, or $89.7 billion less. The program costs about $48 million a year to run and would bring in $44.8 million, a loss of about $3.2 million a year. Audits of payment years 2011 through 2015, which were limited to the sampled enrollees, found $37.6 million of improper payments across 29,900 people.
How a contract audit extrapolates and where the FFS adjuster fits
Each audited HCC requires one submitted medical record, about 336 records per contract, the rule's paperwork estimate says. Where the record fails to support a diagnosis, the enrollee's risk score is recalculated. The average change across the sample is then used to estimate a payment error for the "larger universe of enrollees" in the contract, within confidence intervals.
The $90.2 billion is built the same way. CMS took the $1,258 average overpayment per sampled enrollee from the 2011 to 2015 audits, held it constant, and applied it to about 71.7 million sampling-frame enrollees across 8,260 contract audits over ten years. The agency also proposed auditing sub-cohorts, such as enrollees with diabetes HCCs, which it said would allow smaller samples spread over more contracts.
Plans have argued since 2010 that the audit standard and the payment model are mismatched. The CMS-HCC model is calibrated on FFS claims, and the plans say the diagnoses on those claims go unaudited. Coefficients built on them, the argument runs, understate the cost of a documented condition, so recoveries need an offset to preserve the "actuarial equivalence" the statute requires. CMS's 2012 methodology promised such an adjuster. The agency "never calculated or implemented" one, the rule says.
CMS proposed none. It cited the D.C. Circuit's 2021 decision in UnitedHealthcare v. Becerra, which held that the equivalence provision is an instruction on the design of the risk model and "does not directly govern how CMS evaluates the validity of diagnoses or defines 'overpayment.'" That case concerned a rule on self-reported overpayments, and CMS said its reasoning "applies just as strongly" to RADV. The agency added that the statute already requires a coding pattern reduction of at least 5.90% a year, and said it would be unreasonable to read the Act as requiring that cut while barring enforcement of documentation rules.
Humana has carried the dispute into its bids. The company "relied on CMS's 2012 guidance in submitting MA bids," its 10-Q says, and ran self-audits for payment years 2011 through 2016 that included an estimated FFS adjuster. Its "actuarially certified bids through PY 2027 preserved Humana's position that CMS should apply an FFS Adjuster in any RADV audit that CMS intends to extrapolate."
Oppenheimer analysts expect the cost of future audits to move into pricing. "We believe plans would incorporate the prospective cost into bids rather than absorb an unchanged recurring earnings burden," the firm said in a note quoted by Yahoo Finance. Oppenheimer also expects the rule to face the kind of legal challenge that brought down the earlier version, the report said.
Payment years already bid and the Fifth Circuit appeal
Bids are already filed for every payment year from 2018 through 2027, and the proposal would cover all ten. CMS argued that nothing in it is retroactive. The agency announced extrapolation in 2010 and 2012 and proposed dropping the adjuster in 2018, it said, and plans "have never been entitled to receive or retain payments associated with HCCs that cannot be validated by medical records."
In case a court disagrees, CMS invoked section 1871(e)(1)(A) of the Social Security Act, which permits a retroactive rule where failing to apply it "would be contrary to the public interest." It pointed to more than $21 billion of estimated Part C overpayments in fiscal 2025, over 5% of Part C payments, and said that sum cannot be recovered without extrapolation. A severability clause would keep extrapolation for later payment years if the earlier ones were struck.
The 2023 rule fell on procedure. The Northern District of Texas vacated it on September 25, 2025, finding it was not a "logical outgrowth" of the 2018 proposal, Humana's 10-Q says, and the government's appeal is pending at the Fifth Circuit as Humana v. Kennedy. Humana's filing also says the 2023 rule "fails to address adequately the statutory requirement of actuarial equivalence."
UnitedHealth's and Humana's latest 10-Qs were filed before the proposal. UnitedHealth's says CMS and the HHS inspector general have selected some of its local plans for RADV audits, which "may result in retrospective adjustments to payments made to the Company's health plans." Humana's says it records an accrual when a loss is probable and can be reasonably estimated, and that the audit program and the lack of an adjuster "could each have a material adverse effect" on its results.
Other large carriers disclose the same exposure. CVS Health's 10-Q says CMS has audited its Medicare Advantage plans and "may require the Company to refund premium payments" where medical records fail to support them. Elevance Health's says CMS announced plans in May 2025 to "substantially increase the scale and pace" of the audits, with an outcome that "could adversely affect our financial condition and results of operations."
CMS said it "may begin to conduct new RADV audits or finalize results from existing audits for multiple payment years before finalizing the policies in this rule," under its existing authority to review records. Comments are due January 19, 2027.
Further Reading
- OIG Seeks $180M From Humana and UnitedHealthcare Over MA Diagnoses: the inspector general's extrapolated audits of high-risk diagnosis codes.
- CMS V28 Model Goes Full-Weight in 2026, Compressing MA Risk Scores: the risk model the audited diagnoses feed.
- CMS Reverses Risk Model Update and Finalizes 2027 MA Rates at 2.48%: the payment year 2027 rates the latest bids were built on.
- UnitedHealth and Humana's MA Exits Trace to County Benchmark Math: how the two carriers priced their 2027 footprints.
Sources
- CMS, Medicare, Medicaid, and Marketplace Programs; Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH), proposed rule CMS-6098-P, Federal Register document 2026-23461, public inspection copy
- CMS, CRUSH Proposed Rule (CMS-6098-P) fact sheet, 16 November 2026
- CMS, "CMS CRUSH Proposed Rule Aims to Reap Nearly $90 Billion for Taxpayers in Savings," press release, 16 November 2026
- Humana Inc., Form 10-Q for the quarter ended 30 September 2026, Note 13, filed 6 November 2026
- UnitedHealth Group Inc., Form 10-Q for the quarter ended 30 September 2026, filed 3 November 2026
- CVS Health Corp., Form 10-Q for the quarter ended 30 September 2026, filed 4 November 2026
- Elevance Health Inc., Form 10-Q for the quarter ended 30 September 2026, filed 21 October 2026
- Yahoo Finance, "UnitedHealth Sinks 12% on CMS Fraud Rule as Warren Says Giants 'Take a Cut at Every Step'," 18 November 2026